Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Bringing Clinical Trials and Healthcare Providers Together to Expand Participation and Accelerate Research with Dr. Matt Wilson uMed TRANSCRIPT
Download PDFJul 26, 2022
Dr. Matt Wilson is the Founder and CEO of uMEd, bringing together healthcare providers and researchers to reach out to patients to participate in clinical trials. Using health data, uMed facilitates targeting good candidates for trials and helps the care provider educate patients about the value of participating in one or multiple clinical trials. In a very repeatable and scalable environment, uMed can match patients to specific study opportunities based on standardized queries.
Matt explains, "A lot of other organizations in the clinical study space that are looking at using health record data are using it in a very different way because they're generally focused on bringing together existing EMR data or claims data from lots of different healthcare providers and using that in of itself to identify trends and value for researchers. Whereas uMed is taking a different approach, saying, "Well, actually, their health record data is incredibly useful as a starting point to be able to identify potential study participants."
"We essentially have a common data infrastructure that sits across our network of healthcare providers, that's bound to the U.K. and now the U.S. as well, which will shortly be coming online. What we do in that network is each of these providers essentially say, "Yes, we want to be part of the uMed network." That allows us to be able to bring the data from those health records and normalize them across all of the different providers we're working with."
#uMed #PatientRecruitment #ClinicalTrials #MedicalResearch #ClinicalTrialRecruitment
